Pharmafile Logo

Free Live Webinar – Patient Recruitment & Retention

Join Innovative Trials and Soglia in this new patient recruitment and retention webinar!

- PMLiVE

How has patient recruitment, retention, and engagement in clinical trials changed over the last 15 years, and what does the future hold? Join us to explore the critical shifts shaping our industry, from the rise of patient centricity and the drive for greater diversity to the impact of AI and the enduring importance of human interaction. Our speakers will share their firsthand experiences, analysing the successes and challenges of traditional and novel engagement techniques. Discover actionable strategies and gain a clear understanding of what will drive effective patient participation in clinical research moving forward.

Speakers

  • Leanne Woehlke – Executive Vice President,  Soglia, a division of Entrada
  • LaQuinta Jernigan – Clinical Trials Commercial Leader
  • Hayley Tilley Associate Director, Patient Recruitment,  Innovative Trials

Register here

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

[Free Case Study Booklet] Accelerating Patient Recruitment in a global rare disease trial

See how Innovative Trials supported a Top 5 pharma to complete enrollment in a Phase 2 Lupus study

Pride Month 2023 – Innovative Trials

Innnovative Trials' Equality & Diversity committee celebrates Pride Month

[Free Whitepaper] 5 Principles for Greater Diversity in Patient Recruitment

Discover how community engagement could enhance diversity in clinical trials patient recruitment

Innovative Trials attended the Inspire Hertfordshire Award gala dinner

Innovative Trials, a global clinical trial patient recruitment and retention company based in Hertfordshire, has been recognised for its contribution to the county’s economy and business reputation.

Navigating patients step by step on their clinical trial journey

For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in...

Innovative Trials responds to national recommendations to tackle UK clinical trial decline

Kate Shaw, Founder & CEO, comments on the Lord report of the Lord O’Shaughnessy review into commercial clinical trials in the UK.

Innovative Trials nominates Eloise Moffett as New VP of Commercial

Eloise Moffett joins Innovative Trials as New Vice President of Commercial to drive business growth globally

Kate Shaw comments the appointment of an independent review on clinical trials in the UK.

The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five...

Patient Recruitment: Think Global, Act Local

Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust...

Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients

Kate Shaw, Innovative Trials' Founder & CEM, reflects on the exciting news for patients affected by cancer in the UK.